Pure Global AI
ANVISA registration 80102513670Valid until Apr 22, 2036

ANTIBODY FOR MULTIPLE HUMAN T-LYMPHOTROPIC VIRUSES (HTLV)

ANVISA Registration Number: 80102513670VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDAAUTOBIO DIAGNOSTICS CO., LTDRisk Class IV
Device names
Technical name
ANTIBODY FOR MULTIPLE HUMAN T-LYMPHOTROPIC VIRUSES (HTLV)
PT: ANTICORPO PARA VÍRUS MÚLTIPLOS DE T-LINFOTRÓPICO HUMANO (HTLV)
Commercial name
Família AutoLumo Anti-HTLV Micropartículas (CLIA)
Risk class
Class IV
Registration details
Registration Number
80102513670
Process Number
25351099759202549
CNPJ
04718143000194
Company information
Manufacturing Country
China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
Publication Date
Apr 22, 2026
Validity
22/04/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTIBODY FOR MULTIPLE HUMAN T-LYMPHOTROPIC VIRUSES (HTLV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80102513670 and manufactured by AUTOBIO DIAGNOSTICS CO., LTD. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until Apr 22, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.